摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-chloro-N-(methylsulfonyl)-4-(2-naphthyloxy)benzamide | 1354955-44-4

中文名称
——
中文别名
——
英文名称
3-chloro-N-(methylsulfonyl)-4-(2-naphthyloxy)benzamide
英文别名
3-chloro-N-methylsulfonyl-4-naphthalen-2-yloxybenzamide
3-chloro-N-(methylsulfonyl)-4-(2-naphthyloxy)benzamide化学式
CAS
1354955-44-4
化学式
C18H14ClNO4S
mdl
——
分子量
375.832
InChiKey
UVUIJIQMIBKHIH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.2
  • 重原子数:
    25
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.06
  • 拓扑面积:
    80.8
  • 氢给体数:
    1
  • 氢受体数:
    4

文献信息

  • Chemical Compounds
    申请人:Bell Andrew Simon
    公开号:US20120010207A1
    公开(公告)日:2012-01-12
    The invention relates to sulfonamide derivatives, to their use in medicine, to compositions containing them, to processes for their preparation and to intermediates used in such processes. More particularly the invention relates to a new sulfonamide Nav1.7 inhibitors of formula (I): or a pharmaceutically acceptable salt thereof, wherein Ar 1 , X, R 1 , R 2 , R 3 , R 4 and R 5 are as defined in the description. Nav 1.7 inhibitors are potentially useful in the treatment of a wide range of disorders, particularly pain.
    该发明涉及磺胺类生物,它们在医学上的应用,含有它们的组合物,用于它们的制备方法以及用于这些方法的中间体。更具体地,该发明涉及一种新的磺胺类Nav1.7抑制剂,其化学式为(I):或其药用可接受的盐,其中Ar1、X、R1、R2、R3、R4和R5如描述中所定义。Nav1.7抑制剂在治疗各种疾病,特别是疼痛方面具有潜在的用途。
  • SULFONAMIDE DERIVATIVES AS NAV1.7 INHIBITORS FOR THE TREATMENT OF PAIN
    申请人:Pfizer Limited
    公开号:EP2593427A1
    公开(公告)日:2013-05-22
  • [EN] SULFONAMIDE DERIVATIVES AS NAV1.7 INHIBITORS FOR THE TREATMENT OF PAIN<br/>[FR] COMPOSÉS CHIMIQUES
    申请人:PFIZER LTD
    公开号:WO2012007883A1
    公开(公告)日:2012-01-19
    The invention relates to sulfonamide derivatives, to their use in medicine, to compositions containing them, to processes for their preparation and to intermediates used in such processes. More particularly the invention relates to a new sulfonamide Nav1.7 inhibitors of formula (I):or a pharmaceutically acceptable salt thereof, wherein Ar1, X, R1, R2, R3, R4 and R5 are as defined in the description. Nav 1.7 inhibitors are potentially useful in the treatment of a wide range of disorders, particularly pain.
查看更多